ID   TNR17_HUMAN             Reviewed;         184 AA.
AC   Q02223; Q2TQ40;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   07-APR-2021, entry version 196.
DE   RecName: Full=Tumor necrosis factor receptor superfamily member 17;
DE   AltName: Full=B-cell maturation protein;
DE   AltName: CD_antigen=CD269;
GN   Name=TNFRSF17; Synonyms=BCM, BCMA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION, AND
RP   VARIANT SER-81.
RC   TISSUE=Lymph node, and Peripheral blood leukocyte;
RX   PubMed=1396583; DOI=10.1002/j.1460-2075.1992.tb05482.x;
RA   Laabi Y., Gras M.P., Carbonnel F., Brouet J.C., Berger R., Larsen C.-J.,
RA   Tsapis A.;
RT   "A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a
RT   t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.";
RL   EMBO J. 11:3897-3904(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND VARIANT SER-81.
RX   PubMed=8165126; DOI=10.1093/nar/22.7.1147;
RA   Laabi Y., Gras M.P., Brouet J.C., Berger R., Larsen C.J., Tsapis A.;
RT   "The BCMA gene, preferentially expressed during B lymphoid maturation, is
RT   bidirectionally transcribed.";
RL   Nucleic Acids Res. 22:1147-1154(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-81 AND THR-153.
RX   PubMed=11528522; DOI=10.1038/sj.gene.6363770;
RA   Kawasaki A., Tsuchiya N., Fukazawa T., Hashimoto H., Tokunaga K.;
RT   "Presence of four major haplotypes in human BCMA gene: lack of association
RT   with systemic lupus erythematosus and rheumatoid arthritis.";
RL   Genes Immun. 2:276-279(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Peripheral blood;
RX   PubMed=17825416; DOI=10.1016/j.molimm.2007.07.028;
RA   Smirnova A.S., Andrade-Oliveira V., Gerbase-DeLima M.;
RT   "Identification of new splice variants of the genes BAFF and BCMA.";
RL   Mol. Immunol. 45:1179-1183(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Maia S., Freeman G.J., Nadler L.M., Cardoso A.A.;
RT   "Novel, secreted isoform of human tumor necrosis factor receptor
RT   superfamily, member 17 (TNFRSF17).";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-54; VAL-65; VAL-75;
RP   SER-81 AND SER-165.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-81.
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R., Fuhrmann J.,
RA   Mason T., Crosby M.L., Barnstead M., Cronin L., Mays A.D., Cao Y., Xu R.X.,
RA   Kang H.-L., Mitchell S., Eichler E.E., Harris P.C., Venter J.C.,
RA   Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from human
RT   chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH TRAF1 AND TRAF3.
RX   PubMed=10903733; DOI=10.4049/jimmunol.165.3.1322;
RA   Hatzoglou A., Roussel J., Bourgeade M.-F., Rogier E., Madry C., Inoue J.,
RA   Devergne O., Tsapis A.;
RT   "TNF receptor family member BCMA (B cell maturation) associates with TNF
RT   receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-
RT   kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein
RT   kinase.";
RL   J. Immunol. 165:1322-1330(2000).
RN   [10]
RP   FUNCTION.
RX   PubMed=10801128; DOI=10.1038/35010115;
RA   Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K.,
RA   Xu W., Parrish-Novak J., Foster D., Lofton-Day C., Moore M., Littau A.,
RA   Grossman A., Haugen H., Foley K., Blumberg H., Harrison K., Kindsvogel W.,
RA   Clegg C.H.;
RT   "TACI and BCMA are receptors for a TNF homologue implicated in B-cell
RT   autoimmune disease.";
RL   Nature 404:995-999(2000).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH TNFSF13 AND TNFSF13B.
RX   PubMed=10973284; DOI=10.1038/79802;
RA   Yu G., Boone T., Delaney J., Hawkins N., Kelley M.J., Ramakrishnan M.,
RA   McCabe S., Qiu W.R., Kornuc M., Xia X.-Z., Guo J., Stolina M., Boyle W.J.,
RA   Sarosi I., Hsu H., Senaldi G., Theill L.E.;
RT   "APRIL and TALL-I and receptors BCMA and TACI: system for regulating
RT   humoral immunity.";
RL   Nat. Immunol. 1:252-256(2000).
RN   [12]
RP   INTERACTION WITH TRAF5 AND TRAF6.
RX   PubMed=10908663; DOI=10.1073/pnas.160213497;
RA   Shu H.-B., Johnson H.;
RT   "B cell maturation protein is a receptor for the tumor necrosis factor
RT   family member TALL-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9156-9161(2000).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 8-46 IN COMPLEX WITH TNFSF13B, AND
RP   DISULFIDE BONDS.
RX   PubMed=12721620; DOI=10.1038/nature01543;
RA   Liu Y., Hong X., Kappler J., Jiang L., Zhang R., Xu L., Pan C.-H.,
RA   Martin W.E., Murphy R.C., Shu H.-B., Dai S., Zhang G.;
RT   "Ligand-receptor binding revealed by the TNF family member TALL-1.";
RL   Nature 423:49-56(2003).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 5-51 IN COMPLEX WITH MOUSE
RP   TNFSF13B, AND DISULFIDE BONDS.
RX   PubMed=15542592; DOI=10.1074/jbc.m411714200;
RA   Hymowitz S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J.,
RA   Shriver S.K., Gordon N.C., Pan B., Skelton N.J., Kelley R.F.,
RA   Starovasnik M.A.;
RT   "Structures of APRIL-receptor complexes: like BCMA, TACI employs only a
RT   single cysteine-rich domain for high affinity ligand binding.";
RL   J. Biol. Chem. 280:7218-7227(2005).
CC   -!- FUNCTION: Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes
CC       B-cell survival and plays a role in the regulation of humoral immunity.
CC       Activates NF-kappa-B and JNK. {ECO:0000269|PubMed:10801128,
CC       ECO:0000269|PubMed:10903733, ECO:0000269|PubMed:10973284}.
CC   -!- SUBUNIT: Associates with TRAF1, TRAF2, TRAF3, TRAF5 and TRAF6.
CC       {ECO:0000269|PubMed:12721620, ECO:0000269|PubMed:15542592}.
CC   -!- INTERACTION:
CC       Q02223; Q96FZ5: CMTM7; NbExp=3; IntAct=EBI-519945, EBI-2807956;
CC       Q02223; Q9Y5Y5: PEX16; NbExp=3; IntAct=EBI-519945, EBI-981985;
CC       Q02223; P55061: TMBIM6; NbExp=3; IntAct=EBI-519945, EBI-1045825;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type III membrane
CC       protein. Endomembrane system; Single-pass type III membrane protein.
CC       Note=Perinuclear Golgi-like structures.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q02223-1; Sequence=Displayed;
CC       Name=2; Synonyms=TV4;
CC         IsoId=Q02223-2; Sequence=VSP_047678;
CC   -!- TISSUE SPECIFICITY: Expressed in mature B-cells, but not in T-cells or
CC       monocytes.
CC   -!- DISEASE: Note=A chromosomal aberration involving TNFRSF17 is found in a
CC       form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation
CC       t(4;16)(q26;p13) with IL2. {ECO:0000269|PubMed:1396583}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Observed only in some CD19+ cell.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/tnfrsf17/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z14954; CAA78679.1; -; mRNA.
DR   EMBL; Z29574; CAA82690.1; -; Genomic_DNA.
DR   EMBL; Z29575; CAA82691.1; -; mRNA.
DR   EMBL; AB052772; BAB60895.1; -; Genomic_DNA.
DR   EMBL; EF152355; ABN42510.1; -; mRNA.
DR   EMBL; AY684975; AAV92616.1; -; mRNA.
DR   EMBL; AY509112; AAR84240.1; -; Genomic_DNA.
DR   EMBL; U95742; AAB67251.1; -; Genomic_DNA.
DR   EMBL; AC007216; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS10552.1; -. [Q02223-1]
DR   PIR; S43486; S43486.
DR   RefSeq; NP_001183.2; NM_001192.2. [Q02223-1]
DR   PDB; 1OQD; X-ray; 2.60 A; K/L/M/N/O/P/Q/R=8-46.
DR   PDB; 1XU2; X-ray; 2.35 A; R/S/T=5-51.
DR   PDB; 2KN1; NMR; -; A=2-50.
DR   PDB; 4ZFO; X-ray; 1.90 A; F/K=1-54.
DR   PDB; 6J7W; X-ray; 2.60 A; C/D=6-44.
DR   PDBsum; 1OQD; -.
DR   PDBsum; 1XU2; -.
DR   PDBsum; 2KN1; -.
DR   PDBsum; 4ZFO; -.
DR   PDBsum; 6J7W; -.
DR   BMRB; Q02223; -.
DR   SMR; Q02223; -.
DR   BioGRID; 107080; 23.
DR   IntAct; Q02223; 18.
DR   STRING; 9606.ENSP00000053243; -.
DR   DrugBank; DB15719; Belantamab mafodotin.
DR   GuidetoPHARMACOLOGY; 1889; -.
DR   GlyGen; Q02223; 1 site.
DR   iPTMnet; Q02223; -.
DR   PhosphoSitePlus; Q02223; -.
DR   BioMuta; TNFRSF17; -.
DR   DMDM; 313104029; -.
DR   jPOST; Q02223; -.
DR   MassIVE; Q02223; -.
DR   PaxDb; Q02223; -.
DR   PeptideAtlas; Q02223; -.
DR   PRIDE; Q02223; -.
DR   ProteomicsDB; 58062; -. [Q02223-1]
DR   ProteomicsDB; 61498; -.
DR   ABCD; Q02223; 224 sequenced antibodies.
DR   Antibodypedia; 11568; 670 antibodies.
DR   CPTC; Q02223; 1 antibody.
DR   DNASU; 608; -.
DR   Ensembl; ENST00000053243; ENSP00000053243; ENSG00000048462. [Q02223-1]
DR   Ensembl; ENST00000396495; ENSP00000379753; ENSG00000048462. [Q02223-2]
DR   GeneID; 608; -.
DR   KEGG; hsa:608; -.
DR   UCSC; uc002dbv.3; human. [Q02223-1]
DR   CTD; 608; -.
DR   DisGeNET; 608; -.
DR   GeneCards; TNFRSF17; -.
DR   HGNC; HGNC:11913; TNFRSF17.
DR   HPA; ENSG00000048462; Tissue enhanced (blood, intestine, lymphoid tissue).
DR   MIM; 109545; gene.
DR   neXtProt; NX_Q02223; -.
DR   OpenTargets; ENSG00000048462; -.
DR   PharmGKB; PA36606; -.
DR   VEuPathDB; HostDB:ENSG00000048462.10; -.
DR   eggNOG; ENOG502SF2N; Eukaryota.
DR   GeneTree; ENSGT00940000154485; -.
DR   HOGENOM; CLU_131588_0_0_1; -.
DR   InParanoid; Q02223; -.
DR   OMA; CHLRCSN; -.
DR   OrthoDB; 1334921at2759; -.
DR   PhylomeDB; Q02223; -.
DR   TreeFam; TF337842; -.
DR   PathwayCommons; Q02223; -.
DR   Reactome; R-HSA-5669034; TNFs bind their physiological receptors.
DR   SIGNOR; Q02223; -.
DR   BioGRID-ORCS; 608; 10 hits in 989 CRISPR screens.
DR   ChiTaRS; TNFRSF17; human.
DR   EvolutionaryTrace; Q02223; -.
DR   GeneWiki; TNFRSF17; -.
DR   GenomeRNAi; 608; -.
DR   Pharos; Q02223; Tbio.
DR   PRO; PR:Q02223; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q02223; protein.
DR   Bgee; ENSG00000048462; Expressed in tonsil and 123 other tissues.
DR   ExpressionAtlas; Q02223; baseline and differential.
DR   Genevisible; Q02223; HS.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0002260; P:lymphocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:Reactome.
DR   CDD; cd13414; TNFRSF17; 1.
DR   InterPro; IPR015337; BCMA_Tall-1-bd.
DR   InterPro; IPR043521; TNFR_13C/17.
DR   InterPro; IPR022320; TNFR_17.
DR   PANTHER; PTHR20437; PTHR20437; 1.
DR   Pfam; PF09257; BCMA-Tall_bind; 1.
DR   PIRSF; PIRSF011859; BCMA_Tall-1_bd; 1.
DR   PRINTS; PR01967; TNFACTORR17.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Disulfide bond; Immunity; Membrane;
KW   Proto-oncogene; Receptor; Reference proteome; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..184
FT                   /note="Tumor necrosis factor receptor superfamily member
FT                   17"
FT                   /id="PRO_0000058935"
FT   TOPO_DOM        1..54
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        55..77
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        78..184
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          7..41
FT                   /note="TNFR-Cys"
FT   SITE            3..4
FT                   /note="Breakpoint for translocation to form IL2/TNFRSF17
FT                   oncogene"
FT   DISULFID        8..21
FT                   /evidence="ECO:0000269|PubMed:12721620,
FT                   ECO:0000269|PubMed:15542592"
FT   DISULFID        24..37
FT                   /evidence="ECO:0000269|PubMed:12721620,
FT                   ECO:0000269|PubMed:15542592"
FT   DISULFID        28..41
FT                   /evidence="ECO:0000269|PubMed:12721620,
FT                   ECO:0000269|PubMed:15542592"
FT   VAR_SEQ         44..93
FT                   /note="SVTNSVKGTNAILWTCLGLSLIISLAVFVLMFLLRKINSEPLKDEFKNTG
FT                   -> R (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17825416, ECO:0000303|Ref.5"
FT                   /id="VSP_047678"
FT   VARIANT         54
FT                   /note="A -> V (in dbSNP:rs11570146)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_018755"
FT   VARIANT         65
FT                   /note="I -> V (in dbSNP:rs11570147)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_018756"
FT   VARIANT         75
FT                   /note="F -> V (in dbSNP:rs11570148)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_018757"
FT   VARIANT         81
FT                   /note="N -> S (in dbSNP:rs373496)"
FT                   /evidence="ECO:0000269|PubMed:10493829,
FT                   ECO:0000269|PubMed:11528522, ECO:0000269|PubMed:1396583,
FT                   ECO:0000269|PubMed:8165126, ECO:0000269|Ref.6"
FT                   /id="VAR_018758"
FT   VARIANT         153
FT                   /note="A -> T (in dbSNP:rs150352299)"
FT                   /evidence="ECO:0000269|PubMed:11528522"
FT                   /id="VAR_012234"
FT   VARIANT         165
FT                   /note="C -> S (in dbSNP:rs11570159)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_018759"
FT   VARIANT         176
FT                   /note="E -> D (in dbSNP:rs34546237)"
FT                   /id="VAR_061855"
FT   STRAND          12..15
FT                   /evidence="ECO:0007744|PDB:4ZFO"
FT   TURN            16..19
FT                   /evidence="ECO:0007744|PDB:4ZFO"
FT   STRAND          20..23
FT                   /evidence="ECO:0007744|PDB:4ZFO"
FT   HELIX           24..27
FT                   /evidence="ECO:0007744|PDB:4ZFO"
FT   STRAND          30..32
FT                   /evidence="ECO:0007744|PDB:4ZFO"
FT   HELIX           35..37
FT                   /evidence="ECO:0007744|PDB:4ZFO"
FT   TURN            38..40
FT                   /evidence="ECO:0007744|PDB:4ZFO"
FT   TURN            42..44
FT                   /evidence="ECO:0007744|PDB:2KN1"
SQ   SEQUENCE   184 AA;  20165 MW;  B6D87B3685F66022 CRC64;
     MLQMAGQCSQ NEYFDSLLHA CIPCQLRCSS NTPPLTCQRY CNASVTNSVK GTNAILWTCL
     GLSLIISLAV FVLMFLLRKI NSEPLKDEFK NTGSGLLGMA NIDLEKSRTG DEIILPRGLE
     YTVEECTCED CIKSKPKVDS DHCFPLPAME EGATILVTTK TNDYCKSLPA ALSATEIEKS
     ISAR
//
